Role of N6-Methyladenosine (m6A) mRNA Modification Pathway in Neuroblastoma |
Boston Children’s Hospital / Shuibin Lin, PhD |
Young Investigator Grants |
2017 |
Massachusetts |
Beyond Febrile Neutropenia: Risks Associated with Antibiotic Choice in Children with Leukemia that Undergo Transplant |
Children’s Hospital of Philadelphia / Caitlin Elgarten, MD |
Young Investigator Grants |
2018 |
Pennsylvania |
Identification of Novel Treatment Targets by Exploring the Interaction of Rhabdomyosarcoma-Associated Oncogenes with Cellular Context in a Mouse Model of Rhabdomyosarcoma |
Dana-Farber Cancer Institute / Simone Hettmer |
Young Investigator Grants |
2010 |
Massachusetts |
Histone Modification and Hmgn1 Overexpression as Drivers of B-ALL with Polysomy 21 |
Dana-Farber Cancer Institute / Andrew Lane, MD, PhD |
Young Investigator Grants |
2013 |
Massachusetts |
Development of Targeted DNA-damaging Therapy for ATRX-deficient Pediatric Glioblastoma |
University of Michigan / Carl Koschmann, MD |
Young Investigator Grants |
2014 |
Michigan |
The Role of Inhibition of Apoptosis by C/EBPalpha and C/EBPalpha oncoproteins in AML.
|
The Johns Hopkins University School of Medicine / Ido Paz-Priel, MD |
Young Investigator Grants |
2007 |
Maryland |
Pre-clinical Evaluation of LSD1 Inhibitors for the Treatment of Pediatric Ewing sarcoma: Defining the Biomarkers of Sensitivity and Mechanisms of Resistance |
Research Institute at Nationwide Children's Hospital / Kathleen Pishas, PhD |
Young Investigator Grants |
2016 |
Ohio |
CAMKV as a Target for Immunotherapy in MYCN-Amplified Neuroblastoma |
Children’s Hospital of Philadelphia / Robyn Sussman, PhD |
Young Investigator Grants |
2015 |
Pennsylvania |
Identifying Ewing Sarcoma Developmental Vulnerabilities |
Children’s Hospital Los Angeles / Elena Vasileva, PhD |
Young Investigator Grants |
2023 |
California |
Single Cell Signaling Profiles In High-Risk Pediatric Leukemia |
Stanford University / Kara Davis |
Young Investigator Grants |
2010 |
California |